Patients' perceptions of the value of current vision: Assessment of preference values among patients with subfoveal choroidal neovascularization - The submacular surgery trials vision preference value scale. SST report no. 6

Archives of Ophthalmology

Volumn 122, Issue 12, 2004, Pages 1856-1867

  Bass, Eric B ^a   Marsh, Marta J ^b   Mangione, Carol M ^b   Bressler, Neil M ^b   Childs, Ashley L ^b   Dong, Li Ming ^b   Hawkins, Barbara S ^b   Jaffee, Harris A ^b   Miskala, Päivi H ^b  

^a Division of General Internal Medicine   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; BLINDNESS; CALCULATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; EYE MALFORMATION; HEALTH STATUS; HEALTH SURVEY; HUMAN; MEASUREMENT; PERCEPTION; PRIORITY JOURNAL; QUALITY OF LIFE; SUBRETINAL NEOVASCULARIZATION; SURGICAL TECHNIQUE; TIME; VISION; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; BLINDNESS; CHOROIDAL NEOVASCULARIZATION; CROSS-SECTIONAL STUDIES; FEMALE; FOVEA CENTRALIS; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PATIENTS; QUALITY OF LIFE; QUESTIONNAIRES; VISION;

EID: 10044280357     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.122.12.1856     Document Type: Article

References (31)

1. Leibowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study Monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol. 1980;24(suppl):335-610.
2. Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause-specific prevalence of blindness in East Baltimore. N Engl J Med. 1991;325:1412-1417.
3. Klein R, Wang Q, Klein BEK, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci. 1995;36:182-191.
4. Rahmani B, Tielsch JM, Gottsch J, Quigley H, Javitt J, Sommer A. The cause-specific prevalence of visual impairment in an urban population: the Baltimore Eye Survey. Ophthalmology. 1996;103:1721-1726.
5. Macular Photocoagulation Study Group. Argon laser photocoagulation for ocular histoplasmosis: results of a randomized clinical trial. Arch Ophthalmol. 1983;101:1347-1357.
6. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis: results of a randomized clinical trial. Arch Ophthalmol. 1987;105:1499-1507.
7. Saaddine JB, Narayan KMV, Vinicor F. Vision loss: a public health problem? Ophthalmology. 2003;110:253-254.
8. Torrance GW. Measurement of health state utilities for economic appraisal: a review. J Health Econ. 1986;5:1-30.
9. Fryback DG, Dasbach EJ, Klein R, et al. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making. 1993;13:89-102.
10. Bass EB, Wills S, Scott IU, et al. Preference values for visual states in patients planning to undergo cataract surgery. Med Decis Making. 1997;17:324-330.
11. Brown MM, Sharma S, Brown MM, Garrett S. Quality in Medicine Study Research Group: evidenced-based medicine and cost-effectiveness. J Health Care Finance. 1999;26:14-23.
12. Submacular Surgery Trials Pilot Study Investigators. Submacular Surgery Trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration, II: quality of life outcomes - SST Pilot Study report No. 2. Am J Ophthalmol. 2000;130:408-418.
13. Morimoto T, Fukui T. Utilities measured by rating scale, time trade-off, and standard gamble: review and reference for health care professionals. J Epidemiol. 2002;12:160-178.
14. Brown GC, Sharma S, Brown MM, Kistler J. Utility values and age-related macular degeneration. Arch Ophthalmol. 2000;118:47-51.
15. Froberg DG, Kane RL. Methodology for measuring health-state preferences, II: Scaling methods. J Clin Epidemiol. 1989;42:459-471.
16. Ryan M, Scott DA, Reeves C, et al. Eliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess. 2001;5:1-186.
17. Ware JE, Sherbourne CD. The MOS 36-Item Short Form Health Survey (SF-36), I: conceptual framework and item selection. Med Care. 1992;30:473-483.
18. Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD; NEI-VFQ Field Test Investigators. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Arch Ophthalmol. 1998;116:1496-1504.
19. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361-370.
20. Torrance GW. Utility approach to measuring health-related quality of life. J Chronic Dis. 1987;40:593-600.
21. Havranek EP, McGovern KM, Weinberger J, et al. Patient preferences for heart failure treatment: utilities are valid measures of health-related quality of life in heart failure. J Card Fail. 1999;5:85-91.
22. Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care. 1989;5:559-575.
23. Post PN, Stiffelbout AM, Wakker PP. The utility of health states after stroke: a systematic review of the literature. Stroke. 2001;32:1425-1429.
24. Ghafour IM, Allan D, Foulds WS. Common causes of blindness and visual handicap in the west of Scotland. Br J Ophthalmol. 1983;67:209-213.
25. Gibson JM, Lavery JR, Rosenthal AR. Blindness and partial sight in an elderly population. Br J Ophthalmol. 1986;70:700-705.
26. Jonasson F, Thordarson K. Prevalence of ocular disease and blindness in a rural area in the eastern region of Iceland during 1980 through 1984. Acta Ophthalmol Suppl. 1987;182:40-43.
27. Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia: the Blue Mountains Eye Study. Ophthalmology. 1996;103:357-364.
28. Rosenberg T, Klie F. Current trends in newly registered blindness in Denmark. Acta Ophthalmol Scand. 1996;74:395-398.
29. Brown MM, Brown GC, Sharma S, Busbee B, Brown H. Quality of life associated with unilateral and bilateral good vision. Ophthalmology. 2001;108:643-647.
30. Pieramici DJ, Bressler NM, Bressler SB, Schachat AP. Choroidal neovascularization in black patients. Arch Ophthalmol. 1994;112:1043-1046.
31. Cost-effectiveness in Health and Medicine. Project Summary. From the Report of the Panel on Cost-Effectiveness in Health and Medicine. Washington, DC: Office of Public Health and Science, US Public Health Service; 1996.